Ansell.qxp 29/7/08 10:18 Page 25
Monitoring of Anticoagulated Patients
warfarin therapy by a whole blood capillary capillary whole blood coagulation
coagulation monitor, Thromb Res, monitors suitable for the control of oral
1992;66:583–90. anticoagulant treatment by the international
10. Weibert RT, Adler DS, Evaluation of a capillary normalized ratio?, Thromb Haemost,
whole blood prothrombin time measurement 1993;70:921–4.
system, Clin Pharm, 1989;8:864–7. 27. Beythe RJ, Quinn L, Landefeld C, A
11. Rose VL, Dermott SC, Murray BF, et al. multicomponent intervention to prevent major
Decentralized testing for prothrombin time and bleeding complications in older patients
activated partial thromboplastin time using a receiving warfarin, Ann Intern Med,
dry chemistry portable analyzer, Arch Pathol Lab 2000;133:687–95.
Med, 1993;117:611–17. 28. Kortke H, Korfer R, International normalized ratio
12. Fabbrini N, Messmore H, Balbale S, et al., Pilot self-management after mechanical
study to determine use of a TAS analyzer in an heart valve replacement: is an early start
anticoagulation clinic setting (abstract), Blood, advantageous?, Ann Thorac Surg, 2001;72:44–8.
1995;86:869a. 29. Watzke HH, Forberg E, Svolba G, et al., A
13. Ansell JA, Zweig S, Meyer B, et al., Performance prospective controlled trial comparing weekly
of the AvocetPT prothrombin time system, Blood, self-testing and self-dosing with the standard
1998;9:112b. management of patients on stable oral
14. Gosselin R, Owings JT, White RH, et al., A anticoagulation, Thromb Haemost,
comparison of point-of-care instruments 2000;83:661–5.
designed for monitoring oral anticoagulation 30. Menendez-Jandula B, Souto JC, Oliver A, et al.,
with standard laboratory methods, Thromb Comparing self-management of oral
Haemost, 2000;83:698–703. anticoagulant therapy with clinic management,
15. Van den Besselaar AM, A comparison of INRs Ann Intern Med, 2005;142:1–10.
determined with a whole blood prothrombin 31. Fitzmaurice DA, Murray ET, Gee KM, et al.,
time device and two international reference J Clin Path, 2002;55:845–9.
preparations for thromboplastin, Thromb Haemost, 32. White RH, McCurdy A, Marensdorff H, et al.,
2000;84:410–12. Home prothrombin time monitoring after the
16. Kitchen S, Preston FE, Monitoring oral initiation of warfarin therapy: a randomized,
anticoagulant treatment with the TAS near prospective study, Ann Intern Med, 1989;111:
patient test system: comparison with 730–37.
conventional thromboplastins, J Clin Pathol, 33. Kaatz S, Elston-Lafata J, Gooldy S,
1997;50:951–6. Anticoagulation therapy home and office
17. Douketis JD, Lane A, Milne J, et al., Accuracy of monitoring evaluation study, J Thromb Thrombolysis,
a portable international normalization ratio 2001;12:111.
monitor in outpatients receiving long-term oral 34. Sidhu P, O’Kane HO, Self-managed
anticoagulant therapy: comparison with a anticoagulation: results from a two-year
laboratory reference standard using clinically prospective randomized trial with heart valve
relevant criteria for agreement, Thromb Res, patients, Ann Thorac Surg, 2001;72:1523–7.
1998:92:11–17. 35. Sunderji R, Gin K, Shalansky K, et al., Canad J
18. Cosmi B, Palareti G, Moia M, et al., Accuracy of Cardiol, 2004;20:1117–23.
a portable prothrombin time monitor 36. Voller H, Glatz J, Taborski U, et al., Zeitschrift fuer
(CoaguChek) in patients on chronic oral Kardiologie, 2005;94:182–6.
anticoagulant therapy, Thromb Res, 37. Kahn TI, Kamali F, Kesteven P, et al., The value of
2000;100:279–86. education and self-monitoring in the
19. Earp B, Hambleton J, Spencer F, et al., Accuracy management of warfarin therapy in older
and precision of the LifeScan INR monitor in patients with unstable control of
anticoagulation clinics, J Thromb Thrombolysis, anticoagulation, Br J Haematol, 2004;126:
2001;12:109. 557–64.
29. Oral Anticoagulation Monitoring Study Group, 38. Poller L, Keown M, Chauhan N, et al., European
Prothrombin measurement using a patient self- concerted action on anticoagulation: multicentre
testing system, Am J Clin Pathol, international sensitivity index calibration of two
2001;115:280–87. types of point-of-care prothrombin time monitor
21. Oral Anticoagulation Monitoring Study systems, Br J Haematol, 2002;116:844–50.
Group, Point-of-care prothrombin time 39. Horstkotte D, Piper C, Wiemer M, et al.,
measurement for professional and patient self- Improvement of prognosis by home prothrombin
testing use, Am J Clin Pathol, 2001;115: estimation in patients with life-long
288–96. anticoagulation therapy, Eur Heart J, 1996;17:230.
22. Andrew M, Marzinotto V, Adams M, et al., 40. Sawicki PT, A structured teaching and self-
Monitoring of anticoagulant therapy in pediatric management program for patients receiving oral
patients using a new microsample PT device, anticoagulation: a randomized controlled trial:
Blood, 1995; 86:863a. working group for the study of patient self-
23. Cachia PG, McGregor E, Adlakha S, et al., management of oral anticoagulation, JAMA,
Accuracy and precision of the TAS analyzer for 1999;281:145–50.
near-patient INR testing by non-pathology staff 41. Fitzmaurice DA, Murray ET, Gee KM, et al.,
in the community, J Clin Pathol, 1998;51: J Clin Pathol, 2002;55:845–9.
68–72. 42. Heneghan C, Alonso-Coello P, Garcia-Alamino
24. Murray ET, Greaves M, INRs and point-of-care JM, et al., Self-monitoring of oral
testing, BMJ, 2003;327:5–6. anticoagulation: a systematic review and
25. Jennings I, Luddington RJ, Baglin T, Evaluation of meta-analysis, Lancet, 2006;367:404–11.
the Ciba-Corning Biotrack 512 coagulation 43. Christensen TD, Self-management of oral
monitor for the control of oral coagulation, anticoagulant therapy: a review, J Thromb
J Clin Pathol, 1991;44:950–53. Thrombolysis, 2004;18(2):127–43.
26. Tripodi A, Arbini AA, Chantarangkul V, et al., Are
US CARDIOLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84